Posttranscriptional and posttranslational determinants of cyclooxygenase expression

Cyclooxygenases (COX-1 and COX-2) are ER-resident proteins that catalyze the committed step in prostanoid synthesis. COX-1 is constitutively expressed in many mammalian cells, whereas COX-2 is usually expressed inducibly and transiently. Abnormal expression of COX-2 has been implicated in the pathog...

Full description

Saved in:
Bibliographic Details
Published inBMB reports Vol. 42; no. 9; pp. 552 - 560
Main Authors Mbonye, Uri R., Case Western Reserve University, Cleveland, OH, USA, Song, I.S., University of Seoul, Seoul, Republic of Korea
Format Journal Article
LanguageEnglish
Published Korea (South) 30.09.2009
Subjects
Online AccessGet full text
ISSN1976-6696
DOI10.5483/bmbrep.2009.42.9.552

Cover

Abstract Cyclooxygenases (COX-1 and COX-2) are ER-resident proteins that catalyze the committed step in prostanoid synthesis. COX-1 is constitutively expressed in many mammalian cells, whereas COX-2 is usually expressed inducibly and transiently. Abnormal expression of COX-2 has been implicated in the pathogenesis of chronic inflammation and various cancers; therefore, it is subject to tight and complex regulation. Differences in regulation of the COX enzymes at the posttranscriptional and posttranslational levels also contribute significantly to their distinct patterns of expression. Rapid degradation of COX-2 mRNA has been attributed to AU-rich elements (AREs) at its 3' UTR. Recently, microRNAs that can selectively repress COX-2 protein synthesis have been identified. The mature forms of these COX proteins are very similar in structure except that COX-2 has a unique 19-amino acid (19-aa) segment located near the C-terminus. This C-terminal 19-aa cassette plays an important role in mediation of the entry of COX-2 into the ER-associated degradation (ERAD) system, which transports ER proteins to the cytoplasm for degradation by the 26S proteasome. A second pathway for COX-2 protein degradation is initiated after the enzyme undergoes suicide inactivation following cyclooxygenase catalysis. Here, we discuss these molecular determinants of COX-2 expression in detail.
AbstractList Cyclooxygenases (COX-1 and COX-2) are ER-resident proteins that catalyze the committed step in prostanoid synthesis. COX-1 is constitutively expressed in many mammalian cells, whereas COX-2 is usually expressed inducibly and transiently. Abnormal expression of COX-2 has been implicated in the pathogenesis of chronic inflammation and various cancers; therefore, it is subject to tight and complex regulation. Differences in regulation of the COX enzymes at the posttranscriptional and posttranslational levels also contribute significantly to their distinct patterns of expression. Rapid degradation of COX-2 mRNA has been attributed to AU-rich elements (AREs) at its 3' UTR. Recently, microRNAs that can selectively repress COX-2 protein synthesis have been identified. The mature forms of these COX proteins are very similar in structure except that COX-2 has a unique 19-amino acid (19-aa) segment located near the C-terminus. This C-terminal 19-aa cassette plays an important role in mediation of the entry of COX-2 into the ER-associated degradation (ERAD) system, which transports ER proteins to the cytoplasm for degradation by the 26S proteasome. A second pathway for COX-2 protein degradation is initiated after the enzyme undergoes suicide inactivation following cyclooxygenase catalysis. Here, we discuss these molecular determinants of COX-2 expression in detail. [BMB reports 2009; 42(9): 552-560].
Cyclooxygenases (COX-1 and COX-2) are ER-resident proteins that catalyze the committed step in prostanoid synthesis. COX-1 is constitutively expressed in many mammalian cells, whereas COX-2 is usually expressed inducibly and transiently. Abnormal expression of COX-2 has been implicated in the pathogenesis of chronic inflammation and various cancers; therefore, it is subject to tight and complex regulation. Differences in regulation of the COX enzymes at the posttranscriptional and posttranslational levels also contribute significantly to their distinct patterns of expression. Rapid degradation of COX-2 mRNA has been attributed to AU-rich elements (AREs) at its 3' UTR. Recently, microRNAs that can selectively repress COX-2 protein synthesis have been identified. The mature forms of these COX proteins are very similar in structure except that COX-2 has a unique 19-amino acid (19-aa) segment located near the C-terminus. This C-terminal 19-aa cassette plays an important role in mediation of the entry of COX-2 into the ER-associated degradation (ERAD) system, which transports ER proteins to the cytoplasm for degradation by the 26S proteasome. A second pathway for COX-2 protein degradation is initiated after the enzyme undergoes suicide inactivation following cyclooxygenase catalysis. Here, we discuss these molecular determinants of COX-2 expression in detail.
Cyclooxygenases (COX-1 and COX-2) are ER-resident proteins that catalyze the committed step in prostanoid synthesis. COX-1 is constitutively expressed in many mammalian cells, whereas COX-2 is usually expressed inducibly and transiently. Abnormal expression of COX-2 has been implicated in the pathogenesis of chronic inflammation and various cancers; therefore, it is subject to tight and complex regulation. Differences in regulation of the COX enzymes at the posttranscriptional and posttranslational levels also contribute significantly to their distinct patterns of expression. Rapid degradation of COX-2 mRNA has been attributed to AU-rich elements (AREs) at its 3' UTR. Recently, microRNAs that can selectively repress COX-2 protein synthesis have been identified. The mature forms of these COX proteins are very similar in structure except that COX-2 has a unique 19-amino acid (19-aa) segment located near the C-terminus. This C-terminal 19-aa cassette plays an important role in mediation of the entry of COX-2 into the ER-associated degradation (ERAD) system, which transports ER proteins to the cytoplasm for degradation by the 26S proteasome. A second pathway for COX-2 protein degradation is initiated after the enzyme undergoes suicide inactivation following cyclooxygenase catalysis. Here, we discuss these molecular determinants of COX-2 expression in detail. [BMB reports 2009; 42(9): 552-560].Cyclooxygenases (COX-1 and COX-2) are ER-resident proteins that catalyze the committed step in prostanoid synthesis. COX-1 is constitutively expressed in many mammalian cells, whereas COX-2 is usually expressed inducibly and transiently. Abnormal expression of COX-2 has been implicated in the pathogenesis of chronic inflammation and various cancers; therefore, it is subject to tight and complex regulation. Differences in regulation of the COX enzymes at the posttranscriptional and posttranslational levels also contribute significantly to their distinct patterns of expression. Rapid degradation of COX-2 mRNA has been attributed to AU-rich elements (AREs) at its 3' UTR. Recently, microRNAs that can selectively repress COX-2 protein synthesis have been identified. The mature forms of these COX proteins are very similar in structure except that COX-2 has a unique 19-amino acid (19-aa) segment located near the C-terminus. This C-terminal 19-aa cassette plays an important role in mediation of the entry of COX-2 into the ER-associated degradation (ERAD) system, which transports ER proteins to the cytoplasm for degradation by the 26S proteasome. A second pathway for COX-2 protein degradation is initiated after the enzyme undergoes suicide inactivation following cyclooxygenase catalysis. Here, we discuss these molecular determinants of COX-2 expression in detail. [BMB reports 2009; 42(9): 552-560].
Author Song, I.S., University of Seoul, Seoul, Republic of Korea
Mbonye, Uri R., Case Western Reserve University, Cleveland, OH, USA
Author_xml – sequence: 1
  fullname: Mbonye, Uri R., Case Western Reserve University, Cleveland, OH, USA
– sequence: 2
  fullname: Song, I.S., University of Seoul, Seoul, Republic of Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19788855$$D View this record in MEDLINE/PubMed
BookMark eNp9kLtOxDAQRV0s4v0HgFLRbXD8ik0HK14CBFqgtmxngoISO9hZif17ArtQUDDNSDPnjjRnB0188IDQQYFzziQ9sZ2N0OcEY5UzkqucczJB24UqxVQIJbbQTkpvGIuClGQTbY0LKSXn2-jpMaRhiMYnF5t-aII3bWZ8lfU_89aspxUMELvGGz-kLNSZW7o2hI_lK3iTIIOPPkJKI7uHNmrTJthf9130cnnxPLue3j1c3czO7qaOUTVMa2IJqMoJqox1hOOKCsNsSQBqo5wTklVSWeocl4JxaWVBOC0qjK0paxB0Fx2v7vYxvC8gDbprkoO2NR7CImlRipKUmI3g0Rpc2A4q3cemM3GpfzSMwOkKcDGkFKHWrhm-_x4VNK0usP7yrM_vz-fQ6y_PmhGt9Oh5DLM_4d_7_8cOV7HaBG1eY5P07ZzgAo9FOaWfn5OQig
CitedBy_id crossref_primary_10_3390_antiox10030496
crossref_primary_10_1007_s12033_021_00419_3
crossref_primary_10_1165_rcmb_2011_0025RT
crossref_primary_10_1590_0074_02760140311
crossref_primary_10_2119_molmed_2012_00088
crossref_primary_10_1016_j_bbi_2017_06_013
crossref_primary_10_1152_physiolgenomics_00160_2010
crossref_primary_10_3390_ijms21093195
crossref_primary_10_1371_journal_pone_0038972
crossref_primary_10_1016_j_arteri_2018_04_001
crossref_primary_10_1016_j_bcp_2010_06_050
crossref_primary_10_3390_bioengineering10010117
crossref_primary_10_1074_jbc_M114_587576
crossref_primary_10_1186_1742_2094_8_50
crossref_primary_10_1016_j_artere_2018_10_001
crossref_primary_10_1038_srep27275
crossref_primary_10_1016_j_fitote_2024_106189
crossref_primary_10_3390_ijms160612648
crossref_primary_10_1210_en_2011_1438
crossref_primary_10_1371_journal_pone_0031304
crossref_primary_10_1016_j_humimm_2010_12_009
crossref_primary_10_18632_oncotarget_5416
crossref_primary_10_1152_ajpcell_00093_2010
crossref_primary_10_1091_mbc_e11_07_0623
crossref_primary_10_1016_j_bbrc_2013_12_038
crossref_primary_10_1016_j_psyneuen_2014_06_015
crossref_primary_10_1038_jid_2015_41
crossref_primary_10_1042_BCJ20180530
crossref_primary_10_1186_1471_2407_13_511
crossref_primary_10_1152_physiolgenomics_00086_2017
crossref_primary_10_1111_cea_12697
crossref_primary_10_1074_jbc_M111_304220
crossref_primary_10_1016_j_bbrc_2014_07_123
crossref_primary_10_1096_fj_202201984R
crossref_primary_10_1007_s12011_015_0234_6
Cites_doi 10.1128/MCB.21.3.771-780.2001
10.1074/jbc.M305600200
10.1006/abbi.1993.1485
10.1038/ncb0805-766
10.1016/0014-5793(93)80109-8
10.1074/jbc.273.23.14411
10.1016/j.cell.2004.12.038
10.1006/bbrc.2001.6071
10.1006/bbrc.1993.1062
10.1016/j.tibs.2007.09.013
10.1002/(SICI)1097-4652(199809)176:3<495::AID-JCP6>3.0.CO;2-J
10.1021/bi026938h
10.1074/jbc.274.46.32936
10.1194/jlr.R800042-JLR200
10.1006/abbi.2001.2482
10.1172/JCI119626
10.1038/367243a0
10.1002/mc.20232
10.1074/jbc.M009603200
10.1074/jbc.275.20.15314
10.1073/pnas.0601805103
10.1007/3-540-28007-3_2
10.1016/S0090-6980(02)00025-4
10.1074/jbc.M710137200
10.1016/0092-8674(95)90126-4
10.1073/pnas.0406066101
10.1016/S1097-2765(03)00012-1
10.1006/abbi.1999.1646
10.1016/S0092-8674(00)80402-X
10.1038/35068566
10.1074/jbc.273.16.9886
10.1016/S0955-0674(02)00358-7
10.1074/jbc.273.12.6801
10.1074/jbc.M608281200
10.1007/s00018-004-4037-8
10.1083/jcb.200411136
10.1074/jbc.272.11.6943
10.1161/01.ATV.18.12.1922
10.1038/35011103
10.1073/pnas.0705917104
10.1038/384644a0
10.1016/S0090-6980(02)00024-2
10.1074/jbc.M303395200
10.1016/S0169-328X(98)00025-4
10.1172/JCI111151
10.1074/jbc.M605206200
10.1128/MCB.20.12.4265-4274.2000
10.1016/S0090-6980(02)00055-2
10.1074/jbc.M001073200
10.1126/science.294.5548.1871
10.1002/bies.10320
10.1074/jbc.M410006200
10.1016/j.febslet.2006.10.073
10.1042/BJ20030887
10.1074/jbc.M004793200
10.1073/pnas.1430537100
10.1146/annurev.biochem.69.1.145
10.1074/jbc.M207007200
10.1016/j.plipres.2007.01.001
ContentType Journal Article
DBID FBQ
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.5483/bmbrep.2009.42.9.552
DatabaseName AGRIS
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EndPage 560
ExternalDocumentID 19788855
10_5483_BMBRep_2009_42_9_552
KR2010000353
Genre Journal Article
Review
GroupedDBID ---
23N
2WC
53G
5GY
5VS
87B
9ZL
AAFWJ
ACGFO
ACYCR
ADBBV
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
DIK
E3Z
F5P
FBQ
GROUPED_DOAJ
GX1
HH5
HYE
HZB
IPNFZ
JDI
KQ8
RIG
RNS
RPM
TR2
AAYXX
CITATION
OVT
CGR
CUY
CVF
ECM
EIF
NPM
7X8
85H
ID FETCH-LOGICAL-c439t-f2b2e9dc639abc250d36a4b72eefa9cc684d89b3cc586458b812531d00ba7fe63
ISSN 1976-6696
IngestDate Thu Sep 04 18:24:39 EDT 2025
Thu Apr 03 07:01:59 EDT 2025
Tue Jul 01 01:58:32 EDT 2025
Thu Apr 24 22:57:04 EDT 2025
Thu Apr 03 09:43:53 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c439t-f2b2e9dc639abc250d36a4b72eefa9cc684d89b3cc586458b812531d00ba7fe63
Notes A50
2010000353
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink http://society.kisti.re.kr/sv/SV_svpsbs03V.do?method=download&cn1=JAKO200910103426007
PMID 19788855
PQID 67672704
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_67672704
pubmed_primary_19788855
crossref_citationtrail_10_5483_BMBRep_2009_42_9_552
crossref_primary_10_5483_BMBRep_2009_42_9_552
fao_agris_KR2010000353
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-09-30
PublicationDateYYYYMMDD 2009-09-30
PublicationDate_xml – month: 09
  year: 2009
  text: 2009-09-30
  day: 30
PublicationDecade 2000
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle BMB reports
PublicationTitleAlternate BMB Rep
PublicationYear 2009
References key-10.5483/BMBRep.2009.42.9.552-10
key-10.5483/BMBRep.2009.42.9.552-54
key-10.5483/BMBRep.2009.42.9.552-11
key-10.5483/BMBRep.2009.42.9.552-55
key-10.5483/BMBRep.2009.42.9.552-12
key-10.5483/BMBRep.2009.42.9.552-13
key-10.5483/BMBRep.2009.42.9.552-57
key-10.5483/BMBRep.2009.42.9.552-50
key-10.5483/BMBRep.2009.42.9.552-51
key-10.5483/BMBRep.2009.42.9.552-52
key-10.5483/BMBRep.2009.42.9.552-18
key-10.5483/BMBRep.2009.42.9.552-19
key-10.5483/BMBRep.2009.42.9.552-14
key-10.5483/BMBRep.2009.42.9.552-58
key-10.5483/BMBRep.2009.42.9.552-15
key-10.5483/BMBRep.2009.42.9.552-59
key-10.5483/BMBRep.2009.42.9.552-16
key-10.5483/BMBRep.2009.42.9.552-17
key-10.5483/BMBRep.2009.42.9.552-60
key-10.5483/BMBRep.2009.42.9.552-21
key-10.5483/BMBRep.2009.42.9.552-65
key-10.5483/BMBRep.2009.42.9.552-22
key-10.5483/BMBRep.2009.42.9.552-66
key-10.5483/BMBRep.2009.42.9.552-23
key-10.5483/BMBRep.2009.42.9.552-67
key-10.5483/BMBRep.2009.42.9.552-68
key-10.5483/BMBRep.2009.42.9.552-61
key-10.5483/BMBRep.2009.42.9.552-62
key-10.5483/BMBRep.2009.42.9.552-63
key-10.5483/BMBRep.2009.42.9.552-64
key-10.5483/BMBRep.2009.42.9.552-29
key-10.5483/BMBRep.2009.42.9.552-25
key-10.5483/BMBRep.2009.42.9.552-69
key-10.5483/BMBRep.2009.42.9.552-26
key-10.5483/BMBRep.2009.42.9.552-4
key-10.5483/BMBRep.2009.42.9.552-3
key-10.5483/BMBRep.2009.42.9.552-1
key-10.5483/BMBRep.2009.42.9.552-71
key-10.5483/BMBRep.2009.42.9.552-33
key-10.5483/BMBRep.2009.42.9.552-77
key-10.5483/BMBRep.2009.42.9.552-34
key-10.5483/BMBRep.2009.42.9.552-35
key-10.5483/BMBRep.2009.42.9.552-8
key-10.5483/BMBRep.2009.42.9.552-72
key-10.5483/BMBRep.2009.42.9.552-73
key-10.5483/BMBRep.2009.42.9.552-6
key-10.5483/BMBRep.2009.42.9.552-30
key-10.5483/BMBRep.2009.42.9.552-74
key-10.5483/BMBRep.2009.42.9.552-5
key-10.5483/BMBRep.2009.42.9.552-31
key-10.5483/BMBRep.2009.42.9.552-75
key-10.5483/BMBRep.2009.42.9.552-37
key-10.5483/BMBRep.2009.42.9.552-39
key-10.5483/BMBRep.2009.42.9.552-46
key-10.5483/BMBRep.2009.42.9.552-40
key-10.5483/BMBRep.2009.42.9.552-42
key-10.5483/BMBRep.2009.42.9.552-47
key-10.5483/BMBRep.2009.42.9.552-48
key-10.5483/BMBRep.2009.42.9.552-49
References_xml – ident: key-10.5483/BMBRep.2009.42.9.552-49
  doi: 10.1128/MCB.21.3.771-780.2001
– ident: key-10.5483/BMBRep.2009.42.9.552-66
  doi: 10.1074/jbc.M305600200
– ident: key-10.5483/BMBRep.2009.42.9.552-23
  doi: 10.1006/abbi.1993.1485
– ident: key-10.5483/BMBRep.2009.42.9.552-58
  doi: 10.1038/ncb0805-766
– ident: key-10.5483/BMBRep.2009.42.9.552-75
  doi: 10.1016/0014-5793(93)80109-8
– ident: key-10.5483/BMBRep.2009.42.9.552-77
  doi: 10.1074/jbc.273.23.14411
– ident: key-10.5483/BMBRep.2009.42.9.552-52
  doi: 10.1016/j.cell.2004.12.038
– ident: key-10.5483/BMBRep.2009.42.9.552-74
  doi: 10.1006/bbrc.2001.6071
– ident: key-10.5483/BMBRep.2009.42.9.552-39
  doi: 10.1006/bbrc.1993.1062
– ident: key-10.5483/BMBRep.2009.42.9.552-4
  doi: 10.1016/j.tibs.2007.09.013
– ident: key-10.5483/BMBRep.2009.42.9.552-29
  doi: 10.1002/(SICI)1097-4652(199809)176:3<495::AID-JCP6>3.0.CO;2-J
– ident: key-10.5483/BMBRep.2009.42.9.552-12
  doi: 10.1021/bi026938h
– ident: key-10.5483/BMBRep.2009.42.9.552-13
  doi: 10.1074/jbc.274.46.32936
– ident: key-10.5483/BMBRep.2009.42.9.552-3
  doi: 10.1194/jlr.R800042-JLR200
– ident: key-10.5483/BMBRep.2009.42.9.552-65
  doi: 10.1006/abbi.2001.2482
– ident: key-10.5483/BMBRep.2009.42.9.552-34
  doi: 10.1172/JCI119626
– ident: key-10.5483/BMBRep.2009.42.9.552-15
  doi: 10.1038/367243a0
– ident: key-10.5483/BMBRep.2009.42.9.552-11
  doi: 10.1002/mc.20232
– ident: key-10.5483/BMBRep.2009.42.9.552-69
  doi: 10.1074/jbc.M009603200
– ident: key-10.5483/BMBRep.2009.42.9.552-33
  doi: 10.1074/jbc.275.20.15314
– ident: key-10.5483/BMBRep.2009.42.9.552-16
  doi: 10.1073/pnas.0601805103
– ident: key-10.5483/BMBRep.2009.42.9.552-63
  doi: 10.1007/3-540-28007-3_2
– ident: key-10.5483/BMBRep.2009.42.9.552-73
  doi: 10.1016/S0090-6980(02)00025-4
– ident: key-10.5483/BMBRep.2009.42.9.552-54
  doi: 10.1074/jbc.M710137200
– ident: key-10.5483/BMBRep.2009.42.9.552-31
  doi: 10.1016/0092-8674(95)90126-4
– ident: key-10.5483/BMBRep.2009.42.9.552-46
  doi: 10.1073/pnas.0406066101
– ident: key-10.5483/BMBRep.2009.42.9.552-47
  doi: 10.1016/S1097-2765(03)00012-1
– ident: key-10.5483/BMBRep.2009.42.9.552-55
  doi: 10.1006/abbi.1999.1646
– ident: key-10.5483/BMBRep.2009.42.9.552-50
  doi: 10.1016/S0092-8674(00)80402-X
– ident: key-10.5483/BMBRep.2009.42.9.552-8
  doi: 10.1038/35068566
– ident: key-10.5483/BMBRep.2009.42.9.552-21
  doi: 10.1074/jbc.273.16.9886
– ident: key-10.5483/BMBRep.2009.42.9.552-61
  doi: 10.1016/S0955-0674(02)00358-7
– ident: key-10.5483/BMBRep.2009.42.9.552-17
  doi: 10.1074/jbc.273.12.6801
– ident: key-10.5483/BMBRep.2009.42.9.552-22
  doi: 10.1074/jbc.M608281200
– ident: key-10.5483/BMBRep.2009.42.9.552-60
  doi: 10.1007/s00018-004-4037-8
– ident: key-10.5483/BMBRep.2009.42.9.552-62
  doi: 10.1083/jcb.200411136
– ident: key-10.5483/BMBRep.2009.42.9.552-25
  doi: 10.1074/jbc.272.11.6943
– ident: key-10.5483/BMBRep.2009.42.9.552-35
  doi: 10.1161/01.ATV.18.12.1922
– ident: key-10.5483/BMBRep.2009.42.9.552-14
  doi: 10.1038/35011103
– ident: key-10.5483/BMBRep.2009.42.9.552-51
  doi: 10.1073/pnas.0705917104
– ident: key-10.5483/BMBRep.2009.42.9.552-18
  doi: 10.1038/384644a0
– ident: key-10.5483/BMBRep.2009.42.9.552-40
  doi: 10.1016/S0090-6980(02)00024-2
– ident: key-10.5483/BMBRep.2009.42.9.552-68
  doi: 10.1074/jbc.M303395200
– ident: key-10.5483/BMBRep.2009.42.9.552-10
  doi: 10.1016/S0169-328X(98)00025-4
– ident: key-10.5483/BMBRep.2009.42.9.552-37
  doi: 10.1172/JCI111151
– ident: key-10.5483/BMBRep.2009.42.9.552-19
  doi: 10.1074/jbc.M605206200
– ident: key-10.5483/BMBRep.2009.42.9.552-48
  doi: 10.1128/MCB.20.12.4265-4274.2000
– ident: key-10.5483/BMBRep.2009.42.9.552-6
  doi: 10.1016/S0090-6980(02)00055-2
– ident: key-10.5483/BMBRep.2009.42.9.552-67
  doi: 10.1074/jbc.M001073200
– ident: key-10.5483/BMBRep.2009.42.9.552-5
  doi: 10.1126/science.294.5548.1871
– ident: key-10.5483/BMBRep.2009.42.9.552-59
  doi: 10.1002/bies.10320
– ident: key-10.5483/BMBRep.2009.42.9.552-30
  doi: 10.1074/jbc.M410006200
– ident: key-10.5483/BMBRep.2009.42.9.552-57
  doi: 10.1016/j.febslet.2006.10.073
– ident: key-10.5483/BMBRep.2009.42.9.552-71
  doi: 10.1042/BJ20030887
– ident: key-10.5483/BMBRep.2009.42.9.552-64
  doi: 10.1074/jbc.M004793200
– ident: key-10.5483/BMBRep.2009.42.9.552-72
  doi: 10.1073/pnas.1430537100
– ident: key-10.5483/BMBRep.2009.42.9.552-1
  doi: 10.1146/annurev.biochem.69.1.145
– ident: key-10.5483/BMBRep.2009.42.9.552-26
  doi: 10.1074/jbc.M207007200
– ident: key-10.5483/BMBRep.2009.42.9.552-42
  doi: 10.1016/j.plipres.2007.01.001
SSID ssj0061272
Score 2.0626988
SecondaryResourceType review_article
Snippet Cyclooxygenases (COX-1 and COX-2) are ER-resident proteins that catalyze the committed step in prostanoid synthesis. COX-1 is constitutively expressed in many...
SourceID proquest
pubmed
crossref
fao
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 552
SubjectTerms Cyclooxygenase
ERAD
Gene Expression Regulation, Enzymologic - physiology
Humans
N-glycoprotein
Prostaglandin-Endoperoxide Synthases - genetics
Prostaglandin-Endoperoxide Synthases - metabolism
PROSTAGLANDINAS
PROSTAGLANDINE
PROSTAGLANDINS
Proteasomal degradation
Protein Processing, Post-Translational
RNA Processing, Post-Transcriptional
Title Posttranscriptional and posttranslational determinants of cyclooxygenase expression
URI https://www.ncbi.nlm.nih.gov/pubmed/19788855
https://www.proquest.com/docview/67672704
Volume 42
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELaAHtpLRQuULX3k0BvydnFsJz4CakWL2gOwEjfLzwpplSAaJJZf33EcZx9d2tKLtYo2s958k5lv7PEMQh98WXpOXIGtOjCYam_BDgqGFQf6AQMnNgSK377zkzH9eskuU0v47nRJo4fmfuW5kv9BFa4BruGU7COQ7YXCBfgM-MIICMP4TxiHTrtNcDbp1U8H_9P1SVrqs0tZL2ZqJnV9NwXR4MZCnf-YD1stbvIepT2FHhddV9N2DXR8c7V_NuwXaLrM3i8VPncdbU9rCSIlPvTmD8gJ5jz2mE32kZI5PRBzxo7F2rOd32SxL8CySYaIKJSGgBlDRBHrg1IyFMP-5vkK2Eueqc8XhEglyJFRSmidKSQlUkiQso6ekKKIW_QhnI5eGIhb27ir_0fx2GSQ8nHVXBZoybpX9cMRR8s8LjbR8y5kyA4j_i_QmqteoqfHqVPfFjpfoQcZ6EH2mx5k83qQ1T5b1INspgfbaPz508XxCe6aZWADnLLBnmjihDXAOJU2QGxtzhXVBXHOK2EML6kthc6NYSWnrNTA7MD-2tFIq8I7nu-gjaqu3C7KxIFqSwmKUO0N-LWwWmmfUzfKNedMD1CenpU0XSX50NBkIv-E0wDh_q7rWEnlL9_fARik-gHOTp6ehayNdt87H6D3CRkJDzpscKnK1bc_ZSg-SIoRHaBXEbDZD4mw1MPY60dOYg89m70nb9BGc3Pr3gILbfS7Vt1-AcUihcE
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Posttranscriptional+and+posttranslational+determinants+of+cyclooxygenase+expression&rft.jtitle=BMB+reports&rft.au=Mbonye%2C+Uri+R.&rft.au=Song%2C+In-Seok&rft.date=2009-09-30&rft.issn=1976-6696&rft.volume=42&rft.issue=9&rft.spage=552&rft.epage=560&rft_id=info:doi/10.5483%2FBMBRep.2009.42.9.552&rft.externalDBID=n%2Fa&rft.externalDocID=10_5483_BMBRep_2009_42_9_552
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1976-6696&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1976-6696&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1976-6696&client=summon